Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Noninvasive testing for ventricular arrhythmias.

J Morganroth1

  • 1Department of Medicine, Graduate Hospital, Philadelphia, PA 19146.

Postgraduate Medicine
|March 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A thorough electrocardiogram study of edoxaban, a novel factor Xa inhibitor.

Journal of clinical pharmacology·2011
Same author

Effects of the selective alpha 1a-adrenoceptor antagonist silodosin on ECGs of healthy men in a randomized, double-blind, placebo- and moxifloxacin-controlled study.

Clinical pharmacology and therapeutics·2010
Same author

Evaluation and management of cardiac safety using the electrocardiogram in oncology clinical trials: focus on cardiac repolarization (QTc interval).

Clinical pharmacology and therapeutics·2009
Same author

Cardiac repolarization and the safety of new drugs defined by electrocardiography.

Clinical pharmacology and therapeutics·2006
Same author

Evaluation of the effect on cardiac repolarization (QTc interval) of oncologic drugs.

Ernst Schering Research Foundation workshop·2006
Same author

Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval.

British journal of clinical pharmacology·2001
Same journal

Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

Postgraduate medicine·2026
Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026
Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026
Same journal

Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

Postgraduate medicine·2026
Same journal

Risk of adverse effects of the concomitant use of statins with calcium channel blockers: a systematic review and meta-analysis.

Postgraduate medicine·2026
Same journal

Association between frailty and major chronic disease-free life expectancy: a large community-based longitudinal study.

Postgraduate medicine·2026
See all related articles

Classifying ventricular arrhythmias is key for treatment. Noninvasive tests like Holter monitoring help evaluate benign or potentially lethal arrhythmias, while invasive testing is best for lethal forms.

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Ventricular arrhythmias require classification into benign, potentially lethal, or lethal categories for appropriate management.
  • Most clinical cases involve benign or potentially lethal arrhythmias manageable with noninvasive methods.

Purpose of the Study:

  • To outline the diagnostic approach for ventricular arrhythmias.
  • To emphasize the role of electrocardiographic techniques in evaluating arrhythmia severity.

Main Methods:

  • Utilizing noninvasive electrocardiographic techniques such as continuous Holter monitoring and exercise testing for benign/potentially lethal arrhythmias.
  • Employing invasive electrophysiologic testing for managing lethal ventricular arrhythmias.
  • Implementing quantitative Holter monitoring for baseline assessment and therapeutic efficacy evaluation of antiarrhythmic therapy.

Related Experiment Videos

Main Results:

  • Noninvasive methods are suitable for the majority of ventricular arrhythmia cases.
  • Invasive electrophysiologic testing is indicated for lethal ventricular arrhythmias.
  • Quantitative Holter monitoring is crucial for assessing antiarrhythmic treatment effectiveness and identifying proarrhythmia.

Conclusions:

  • Accurate classification of ventricular arrhythmias guides treatment decisions.
  • Noninvasive and invasive testing play distinct but essential roles in managing ventricular arrhythmias.
  • Ongoing research, such as the Cardiac Arrhythmia Suppression Trial, aims to determine if suppressing arrhythmias prevents sudden cardiac death.